Norman Greenberg

About

Norman Greenberg leads a multi-disciplinary research and development team that is delivering unique therapeutics based on anti-cancer antibodies and T cell receptors identified from the immune repertoires of elite responder patients in multiple indications. During his career in Pharma and Biotech, Norman Greenberg was Senior Vice President for Translational Medicine at Checkmate Pharmaceuticals supporting an innovative CPG based therapy, Vice President of Global Oncology Research at MedImmune/AstraZeneca where his group delivered therapeutics against PDL1, OX40, and other targets and Senior Director of Oncology Research at Pfizer where his group helped delivered a therapeutic targeting 41BB. In his academic career, Norman Greenberg was a Full Member at the Fred Hutchinson Cancer Research Center in Seattle and Associate (Tenured) Professor at Baylor College of Medicine in Houston. Norman Greenberg has been widely recognized for his early work creating the genetically engineered TRAMP mo

Investment Focus

Location

Gaithersburg, US